XO
XOMA Royalty Corp.
XOMA · NASDAQ
$40.17 -7.72% (-$3.36)
Market Cap $503.8M
P/E Ratio 29.16x
Div. Yield -
ROE 29.40%
Bulios Fair Price
$43.23
7.6% upside
Current Price
$40.17
Undervalued Fair Value Overvalued
According to Bulios Fair Price, XOMA is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
5/9Valuation
33 /100
Expensive EV/EBITDA 14.92x
P/S 9.93x
P/B 5.42x
Growth
6 /100
Declining Book val. growth 0.88%
Rev. growth 45.50%
FCF growth N/A
Profitability
92 /100
Strong Net margin 54.77%
Op. margin 17.20%
FCF margin 28.42%
Quality
53 /100
Average ROE 29.40%
ROA 10.22%
Asset turnover 0.19x
Debt
69 /100
Low Current ratio 3.59x
Int. coverage 5.37x
Net debt/EBITDA 1.08x
Stability
28 /100
Unstable Rev. volatility 57.14%
EPS volatility 203.50%
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about XOMA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Owen Hughes Jr.
Employees
14
Headquarters
EmeryVille